
Ozempic Vs. Glucose Monitors (feat. Sharam Fouladgar-Mercer) #685
30.3.2026
0:00
32:50
Yet more GLP1 news this week.
People regain on average 60% of their lost weight within a year of stopping GLP-1 drugs — and the regained weight may be disproportionately fat rather than muscle.
So are a tool that biohackers have known about for years - CGMs - the answer?
Sharam Fouladgar-Mercer is the co-founder of Signos, the first ever FDA-cleared glucose system for weight management.
Follow Sharam Fouladgar-Mercer on LinkedIn.
Weitere Episoden von „Biohacking News by Zestology“



Verpasse keine Episode von “Biohacking News by Zestology” und abonniere ihn in der kostenlosen GetPodcast App.








